Healthcare & Biotech

Fort Lauderdale – – September 08, 2026 -- KIC Ventures issued a corporate clarification confirming that the U.S. Department of Justice dismissed all criminal charges against portfolio company SpineFrontier Inc. on January 17, 2025, and that no current KIC Ventures portfolio company faces ongoing DOJ litigation tied to the matter.

DOJ moved to dismiss all criminal charges against SpineFrontier in January 2025.

The company stated that no KIC Ventures portfolio entity pleaded guilty to any criminal charge arising from the case and that none remains a defendant in related federal litigation. KIC Ventures said it issued the reminder because customers, physicians and investors may still encounter older reports referencing the original allegations without the case's subsequent dismissal.

Fort Washington, Pa. – September 08, 2026 -- ECRI, a global authority on healthcare safety and quality, has appointed Professor Najmedin Meshkati, PhD, to its Board of Trustees, bringing nearly four decades of complex-systems safety research from aviation, nuclear power, and petrochemical operations to the nonprofit's patient safety mission.

Meshkati investigated the world's most scrutinized industrial disasters

Professor Meshkati has examined the BP Texas City Refinery explosion, the Deepwater Horizon oil spill, and the Fukushima Daiichi nuclear disaster. He testified before the U.S. Senate Committee on Commerce, Science, and Transportation as a member of the FAA's independent Expert Panel on Boeing, which reviewed the company's safety management system and safety culture. He currently chairs the State of California's Diablo Canyon Independent Safety Committee.

Shanghai – September 08, 2026 -- Pulnovo Medical's pulmonary artery denervation (PADN) system reduced the risk of clinical worsening by 51% in patients with pulmonary hypertension linked to left heart disease (PH-LHD), according to results from the PADN-HF-PH trial presented at the European Society of Cardiology (ESC) Congress 2026 and simultaneously published in The New England Journal of Medicine.

Trial enrolled 264 patients across multiple centers under academician Yaling Han

The multicenter, randomized controlled study, led by academician Yaling Han of the General Hospital of Northern Theater Command, evaluated PADN as an add-on to guideline-directed medical therapy (GDMT) versus GDMT alone. Corresponding authors on the NEJM paper include Professor Shao-Liang Chen of Nanjing First Hospital and Professor Gregg W. Stone of Mount Sinai Hospital.

Washington – September 08, 2026 -- Independent testing commissioned by the Alliance to Prevent Legionnaires' Disease (APLD) found Legionella bacteria in 17 percent of 109 water samples collected from sinks, showers, hose bibs and other fixtures across the Upper East Side outbreak zone, results the group says expose gaps in New York City's current prevention strategy.

Testing detected live, culturable Legionella pneumophila serogroup 1 across all three sampled zip codes

The independent consultant collected samples in mid-July across zip codes 10128, 10028 and 10075, the area the City identified as the outbreak zone. Legionella was found in 19 buildings, including 10 exterior hose bibs, seven sinks, one shower and a decorative fountain. Positive samples showed Legionella concentrations ranging from less than 1 to 390 CFU/mL, with Legionella pneumophila serogroup 1 confirmed in all three zip codes.

Boston – September 08, 2026 -- TraceLink has integrated its Drug Supply Chain Security Act (DSCSA) compliance solution with Omnicell, Inc. (Nasdaq: OMCL) pharmacy inventory management systems, embedding serialized product verification and traceability directly into hospital medication receiving workflows.

Integration eliminates separate compliance tools during medication receiving

Hospital and health system pharmacies must currently verify, document, and incorporate medication shipments into inventory while resolving compliance exceptions through manual processes that run alongside operational systems. The new integration allows pharmacy teams to verify serialized products, access traceability data, resolve verification exceptions, and complete compliance reporting within Omnicell's central pharmacy inventory management workflows as medications are received.

Rotterdam – September 08, 2026 -- United Imaging has secured CE Mark certification for the uCT SiriuX and uCT SiriuX Ultrix, clearing what the company calls the world's first dual wide-coverage computed tomography family for commercial sale across Europe.

CE Mark Clears Twin-Ring Gantry System for European Sale

The certification covers a platform built on a Twin-Ring Gantry architecture, integrating dual-wide 16 cm Ultrix detectors with two liquid-metal-bearing X-ray tubes. The approval allows United Imaging to bring the systems into clinical use throughout the European market.

Gothenburg – – September 07, 2026 -- Zinzino AB reported group revenue of SEK 282.2 million for August 2026, up 15% from SEK 245.9 million a year earlier, as growth in its direct-sales markets offset a sharp decline at subsidiary Faun Pharma.

Sales markets revenue climbs 16% to SEK 280.9 million in August

Zinzino's core direct-sales business generated SEK 280.9 million in August 2026, up from SEK 242.5 million in the same month last year, a 16% increase that drove the bulk of the group's top-line expansion.

Faun Pharma external sales drop to SEK 1.3 million from SEK 3.4 million

Faun Pharma's external sales fell to SEK 1.3 million in August 2026, down from SEK 3.4 million a year earlier, a decline that partially offset the stronger performance of Zinzino's sales markets and reduced the group's overall growth rate to 15% from the 16% posted by the sales markets alone.

Austin – September 07, 2026 -- The Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center has become the first facility in the United States to enroll in a clinical trial evaluating a next-generation mapping and pulsed field ablation (PFA) system for patients with paroxysmal and persistent atrial fibrillation.

TCAI performs first procedure under global study leadership

Andrea Natale, M.D., executive medical director of TCAI and global principal investigator for the trial, conducted the first procedure using the new catheter system. The trial is designed to assess the safety and efficacy of the technology across both forms of atrial fibrillation, the most common cardiac arrhythmia, which affects millions of patients worldwide.

Lehi, Utah – September 07, 2026 -- Gargle, Inc. has expanded its dental marketing SEO product to include Answer Engine Optimization (AEO) and Generative Engine Optimization (GEO), addressing a shift in how patients search for dental care through AI tools and voice assistants.

Gargle integrates AEO and GEO directly into its existing SEO service without added fees

The dental marketing agency confirmed that existing clients will not need to purchase separate software or add another vendor to access the new capabilities. Jeff Richins, President of Gargle, said the company incorporated the strategies into its current SEO work to give clients added value while preparing for changes in search behavior.

Duluth, Ga. – September 07, 2026 -- Codoxo's Point Zero Payment Integrity solution has won the "AI Innovation in Regulatory & Compliance" category at the 2026 Fierce AI Innovation Awards, recognizing its approach to preventing healthcare payment errors before claims are created.

Point Zero delivered over $20 million in first-year savings for a leading health plan

One leading health plan using Point Zero achieved more than $20 million in first-year savings, exceeding internal projections by 25%, while simultaneously improving provider engagement and coding accuracy. Across its Point Zero deployments, Codoxo reports health plans have realized $12 to $16 in per-member-per-year savings and cut overpayments by as much as 40%.